- CRRC Chair: Dr. Stuart Clark-Price
Risk Group 1 or higher biohazardous agents, all experiments involving human gene therapy, formation of transgenic animals or plants, and the generation and/or use of rDNA (as defined by the NIH Guidelines) to ensure compliance with applicable regulations and institutional policies.
The IRB reviews all research activities, regardless of funding, which involve human research participants. For those performing veterinary research, this would include survey-based research that polls clients, RDVMs or other stakeholders! Even if the questions are about animals, human beings are polled, so IRB approval is required.